ILEX Oncology Company Profile

21:55 EST 23rd January 2019 | BioPortfolio

Based in San Antonio, Texas, ILEX has a marketed product, Campath®, a treatment for patients with refractory chronic lymphocytic leukemia. ILEX is also advancing a robust pipeline of oncology product candidates. The pipeline comprises multiple technologies at all stages of clinical development, including a monoclonal antibody, apoptosis-inducing agents, cytotoxic compounds with novel mechanisms of action, angiogenesis inhibitors and chemoprevention agents.


11550 IH 10 West
San Antonio
United States of America

News Articles [473 Associated News Articles listed on BioPortfolio]

US FDA approves Catalent’s collaborative oncology treatment

Oncology drug Copiktra was developed during a multi-year collaboration between Catalent Pharma and Verastem Oncology.

ESMO Immuno-Oncology Congress: where the community of stakeholders meets

(European Society for Medical Oncology) The European Society for Medical Oncology (ESMO), the leading professional organisation for medical oncology, is pleased to announce the ESMO Immuno-Oncology 20...

bluebird bio and Gritstone Oncology to Collaborate

bluebird bio (NASDAQ:BLUE) and Gritstone Oncology announced Thursday (August 23) in a joint press release the two will research, develop and commercialize oncology cell therapy treatments. The post bl...

Avacta Group event to focus on immuno-oncology advances and role of its technology in the emerging field of science

Dr Josep Tabernero, President of the European Society for Medical Oncology and Head of the Val d'Hebron Institute of Oncology, Barcelona, will give the plenary presentation

Eli Lilly Deepens Its Oncology Offerings with an $8 Billion Acquisition of Loxo Oncology

Eli Lilly and Company announced it was buying Loxo Oncology for $235 per share in cash, which comes to about $8 billion. The acquisition adds a lot of weight to Lilly’s oncology efforts.

The Integrative Oncology Scholars Program: Indoctrinating the next generation of “integrative oncology” believers

"Integrative oncology" involves "integrating" pseudoscience, mysticism, and quackery with science-based oncology and co-opting science-based lifestyle modalities as "alternative" in order to provide c...

Men and women are different: Why medical oncology needs to restate the obvious

(European Society for Medical Oncology) Gender-based approaches to studying and treating disease have remained largely unexplored in medical oncology, despite the field's growing interest in precision...

ESMO Immuno-Oncology Congress showcases new technologies set to improve cancer treatment

(European Society for Medical Oncology) Innovation in immuno-oncology is exploding and new technologies that are set to benefit many patients with cancer are being showcased in the highly diverse arra...

Drugs and Medications [10 Associated Drugs and Medications listed on BioPortfolio]

Neutrexin (trimetrexate glucuronate for injection) [MedImmune Oncology, Inc.]

NEUTREXIN (trimetrexate glucuronate for injection)

Rubraca [Clovis Oncology, Inc.]

These highlights do not include all the information needed to use RUBRACA safely and effectively. See full prescribing information for RUBRACA.RUBRACA (rucaparib) tablets, for oral useInitial U.S. App...

Carboplatin [Sagent Pharmaceuticals]

Carboplatin Injection(carboplatin aqueous solution)

Carboplatin [Meitheal Pharmaceuticals Inc.]

Carboplatin Injection(carboplatin aqueous solution)

Carboplatin [Hospira, Inc.]

Carboplatin Injection

PubMed Articles [1253 Associated PubMed Articles listed on BioPortfolio]

The therapeutic effect of Ilex pubescens extract on blood stasis model rats according to serum metabolomics.

Ilex pubescens Hook. et Arn (MDQ), a traditional Chinese herb, is used in the treatment of cardiovascular diseases. However, the mechanisms underlying the preventive effect of MDQ on blood stasis rema...

Ilex asprella aqueous extracts exert in vivo anti-inflammatory effects by regulating the NF-κB, JAK2/STAT3, and MAPK signaling pathways.

Ilex asprella (Hook. et Arn.) Champ. ex Benth. (IA) is a representative medicinal plant from the South of the Five Ridges of China. Its roots (RIA) and stems (SIA) have been traditionally used for the...

MALDI- and LDI-MS saponin fingerprint of leaves and sticks components of commercial yerba mate (Ilex paraguariensis).

Yerba mate (YM) is massively produced and consumed as an infusion in South America and spreading all over the world. This product is obtained from dried leaves of Ilex paraguariensis Saint Hilaire, mi...

Quercus ilex L. leaves as filters of air Cd, Cr, Cu, Ni and Pb.

The study of particulate matter pollution in urban areas is of great concern due its adverse effects on human health. Roadside vegetation, intercepting and filtering it, contributes to improve air qua...

New triterpenoid saponins from the leaves of Ilex chinensis.

Eight new triterpenoid saponins, including four ursane-type saponins, ilexchinenosides J-M (1-4), and four oleanane-type saponins, ilexchinenosides N-Q (5-8), along with three known triterpenoid sapon...

Clinical Trials [580 Associated Clinical Trials listed on BioPortfolio]

Yerba Mate (Ilex Paraguariensis A.St.-Hil.): Assessment of Cardiovascular Health

Mate or yerba-mate (Ilex paraguariensis A.St.-Hil.) is a native plant from South America highly consumed in this region. Different traditional products (mate, mate tea, chimarrao, tereré)...

Examining Patient Preferences About the IBM Watson Oncology Clinical Decision Support System

The purpose of this study is to learn what cancer patients think about IBM Watson Oncology. IBM Watson Oncology is a computer program designed to help inform oncologists about the best che...

Support of the Sexual Health in Oncology

Implementation of sexual health support program in oncology department. This program is organized in 3 axes. One is to inform the side effects of treatment on sexual health. There is a co...

Clinical Concordance Study Between Watson for Oncology and Clinician Practice

At present, Watson for Oncology has been applied in 14 countries worldwide, including China, the United States, Holland, Thailand, India, Korea, Poland, Slovakia and Bangladesh. In a doubl...

Osteopathic Manipulative Treatment in Oncology Patients' Management

The aim of present study was to study the osteopathic manipulative effects on pain relief and quality of life improvement on hospitalized oncology geriatric patients. A non-randomized comp...

Companies [750 Associated Companies listed on BioPortfolio]

ILEX Oncology

Based in San Antonio, Texas, ILEX has a marketed product, Campath®, a treatment for patients with refractory chronic lymphocytic leukemia. ILEX is also advancing a robust pipeline of oncology product...

ILEX Oncology Incorporated

ILEX Oncology, Inc. is a drug development company focused exclusively on accelerated development of drugs for thetreatment and prevention of cancer. The Company uses its expertise in the identificatio...

Tessman Technology Limited

Tessman Technology is a clinical research organisation focused on the development of investigational agents to treat cancer. The company was established in Edinburgh, Scotland in 1996, and two years l...


Tessman Technology is a clinical research organisation focused on the development of investigational agents to treat cancer. The company was established in Edinburgh, Scotland in 1996, and two years l...

Boston Millennia Partners

Boston Millennia Partners is a private equity investment partnership managing over $700 million in capital. Millennia invests in high-growth businesses in the healthcare and busin...

More Information about "ILEX Oncology" on BioPortfolio

We have published hundreds of ILEX Oncology news stories on BioPortfolio along with dozens of ILEX Oncology Clinical Trials and PubMed Articles about ILEX Oncology for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ILEX Oncology Companies in our database. You can also find out about relevant ILEX Oncology Drugs and Medications on this site too.

Quick Search


Relevant Topic

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Corporate Database Quicklinks

Searches Linking to this Company Record